148 related articles for article (PubMed ID: 10090856)
1. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants.
Hiltke TJ; Bauer ME; Klesney-Tait J; Hansen EJ; Munson RS; Spinola SM
Microb Pathog; 1999 Feb; 26(2):93-102. PubMed ID: 10090856
[TBL] [Abstract][Full Text] [Related]
2. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an isogenic major outer membrane protein-deficient mutant in the human model of Haemophilus ducreyi infection.
Throm RE; Al-Tawfiq JA; Fortney KR; Katz BP; Hood AF; Slaughter CA; Hansen EJ; Spinola SM
Infect Immun; 2000 May; 68(5):2602-7. PubMed ID: 10768950
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection.
Janowicz DM; Zwickl BW; Fortney KR; Katz BP; Bauer ME
BMC Microbiol; 2014 Jun; 14():166. PubMed ID: 24961160
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi.
Sun S; Schilling B; Tarantino L; Tullius MV; Gibson BW; Munson RS
J Bacteriol; 2000 Apr; 182(8):2292-8. PubMed ID: 10735874
[TBL] [Abstract][Full Text] [Related]
6. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.
Young RS; Fortney K; Haley JC; Hood AF; Campagnari AA; Wang J; Bozue JA; Munson RS; Spinola SM
Infect Immun; 1999 Dec; 67(12):6335-40. PubMed ID: 10569746
[TBL] [Abstract][Full Text] [Related]
7. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
8. A novel lectin, DltA, is required for expression of a full serum resistance phenotype in Haemophilus ducreyi.
Leduc I; Richards P; Davis C; Schilling B; Elkins C
Infect Immun; 2004 Jun; 72(6):3418-28. PubMed ID: 15155648
[TBL] [Abstract][Full Text] [Related]
9. Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection.
Fortney KR; Young RS; Bauer ME; Katz BP; Hood AF; Munson RS; Spinola SM
Infect Immun; 2000 Nov; 68(11):6441-8. PubMed ID: 11035757
[TBL] [Abstract][Full Text] [Related]
10. Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations.
White CD; Leduc I; Olsen B; Jeter C; Harris C; Elkins C
Infect Immun; 2005 Apr; 73(4):2387-99. PubMed ID: 15784585
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi.
Alfa MJ; Olson N; Degagne P; Plummer F; Namaara W; Maclean I; Ronald AR
J Infect Dis; 1993 May; 167(5):1206-10. PubMed ID: 8486955
[TBL] [Abstract][Full Text] [Related]
12. Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.
Abdullah M; Nepluev I; Afonina G; Ram S; Rice P; Cade W; Elkins C
Infect Immun; 2005 Jun; 73(6):3431-9. PubMed ID: 15908371
[TBL] [Abstract][Full Text] [Related]
13. A DltA mutant of Haemophilus ducreyi Is partially attenuated in its ability to cause pustules in human volunteers.
Janowicz D; Leduc I; Fortney KR; Katz BP; Elkins C; Spinola SM
Infect Immun; 2006 Feb; 74(2):1394-7. PubMed ID: 16428791
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic analysis of the Haemophilus ducreyi porin-deficient mutant 35000HP::P2AB.
Davie JJ; Campagnari AA
J Bacteriol; 2009 Apr; 191(7):2144-52. PubMed ID: 19103932
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the lspA1 and lspA2 genes of Haemophilus ducreyi affect the virulence of this pathogen in an animal model system.
Ward CK; Latimer JL; Nika J; Vakevainen M; Mock JR; Deng K; Blick RJ; Hansen EJ
Infect Immun; 2003 May; 71(5):2478-86. PubMed ID: 12704119
[TBL] [Abstract][Full Text] [Related]
16. Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers.
Janowicz D; Luke NR; Fortney KR; Katz BP; Campagnari AA; Spinola SM
Microb Pathog; 2006 Mar; 40(3):110-5. PubMed ID: 16426809
[TBL] [Abstract][Full Text] [Related]
17. Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA.
Elkins C; Morrow KJ; Olsen B
Infect Immun; 2000 Mar; 68(3):1608-19. PubMed ID: 10678980
[TBL] [Abstract][Full Text] [Related]
18. A Class I
Leduc I; Fortney KR; Janowicz DM; Zwickl B; Ellinger S; Katz BP; Lin H; Dong Q; Spinola SM
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31036601
[No Abstract] [Full Text] [Related]
19. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
[TBL] [Abstract][Full Text] [Related]
20. Localisation and immunological properties of a 24-kDa surface protein of Haemophilus ducreyi.
Frisk A; Roggen EL; Lagergård T
J Med Microbiol; 1995 Sep; 43(3):192-200. PubMed ID: 7650727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
